Filing Details

Accession Number:
0000950170-25-003160
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-01-07 20:02:51
Reporting Period:
2025-01-03
Accepted Time:
2025-01-07 20:02:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1880438 An2 Therapeutics Inc. ANTX Pharmaceutical Preparations (2834) 820606654
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1914510 Lucy Day C/O An2 Therapeutics, Inc.
1800 El Camino Real, Suite D
Menlo Park CA 94027
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-01-03 2,957 $1.34 32,670 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2025.
  2. Includes 20,625 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.
  3. Includes 5,000 shares purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from reporting under Section 16(b)3.